Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations

BACKGROUND: Historically, three founder mutations in the BRCA1/2 (OMIM 113705; OMIM 600185) genes have been the focus of cancer risks within the Ashkenazi Jewish (AJ) population. However, there are several additional mutations associated with increased susceptibility to cancer in individuals of AJ a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Devin M., Nelson, Katherine L., Clytone, Meera, Collins, Debra L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305650/
https://www.ncbi.nlm.nih.gov/pubmed/30152102
http://dx.doi.org/10.1002/mgg3.460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305650/
https://www.ncbi.nlm.nih.gov/pubmed/30152102
http://dx.doi.org/10.1002/mgg3.460

Ejemplares similares